Epigenetic modification of PKMζ rescues aging-related cognitive impairment

Chen Chen1,2, Shi-Qiu Meng1,2, Yan-Xue Xue2

  • 1Institute of Mental Health, Peking University Sixth Hospital, and Key Laboratory of Mental Health, Beijing 100191, China.

Scientific Reports
|March 2, 2016
PubMed

Insights

Aging impairs cognition due to changes in protein kinase Mζ (PKMζ) DNA methylation. Restoring PKMζ levels in the brain

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Aging Research

Background:

  • Cognitive decline is a common consequence of aging.
  • The molecular mechanisms driving age-related cognitive impairment remain largely unknown.
  • Protein kinase Mζ (PKMζ) plays a vital role in maintaining long-term memory.

Purpose of the Study:

  • To investigate the role of DNA methylation of PKMζ in the prelimbic cortex (PrL) in age-related cognitive decline.
  • To explore PKMζ as a potential therapeutic target for improving cognitive function in aged individuals.

Main Methods:

  • Behavioral testing (e.g., fear conditioning, memory retention tests) in young, adult, and aged rats.
  • Analysis of DNA methylation patterns of PKMζ in the PrL.
  • Assessment of PKMζ protein levels and GluR2 membrane expression.
  • Intervention studies involving PKMζ overexpression and environmental enrichment.

Main Results:

  • Aged rats exhibited significant cognitive impairment in memory retention.
  • Cognitive decline correlated with altered DNA methylation of PKMζ in the PrL.
  • Overexpression of PKMζ rescued cognitive deficits in aged rats.
  • Environmental enrichment reversed PKMζ hypermethylation and improved cognitive performance in aged rats.

Conclusions:

  • Changes in PKMζ DNA methylation in the PrL are linked to aging-associated cognitive impairment.
  • PKMζ represents a promising therapeutic target for mitigating age-related cognitive decline.
  • Environmental enrichment can positively modulate PKMζ methylation and cognitive function in aging.